November 2022 updates to the website
16 November 2022
The website has now been updated following November's LSCMMG
The following guidelines have been added/updated:
Generic biosimilar medicines position statement - updated
Nutritional supplement post-bariatric surgery position statement - updated
Oral Nutritional Supplements Guideline - website update to follow
Menopause Guideline - website update to follow
The following Items have been updated and added to the website following the latest Pharmacy and Medicines Policy Task and Finish Group Meeting:
Trimbow MDI - Asthma
Hydrocortisone sodium phosphate eye drops (Softacort) - Treatment of mild non-infectious allergic or inflammatory conjunctival diseases
Dexamethasone intravitreal implant - treating diabetic macular oedema (NICE TA824)
Icosapent ethyl with statin therapy - for reducing the risk of cardiovascular events in people with raised triglycerides (NICE TA805)
The following Items will be updated and added to the website following the next Pharmacy and Medicines Policy Task and Finish Group Meeting:
Ozanimod - moderately to severely active ulcerative colitis (NICE TA828)
Upadacitinib - active ankylosing spondylitis (NICE TA829)
Fostamatinib - refractory chronic immune thrombocytopenia (NICE TA835)
Relugolix–estradiol–norethisterone acetate - moderate to severe symptoms of uterine fibroids (NICE TA832)